FactMR today released its latest report on the Structural Heart Devices Market, forecasting robust growth driven by rising cardiovascular disease prevalence, advancements in minimally invasive procedures, and an aging global population. Valued at USD 12.17 billion in 2023, the global market is projected to expand at a compound annual growth rate (CAGR) of 11%, reaching USD 36.06 billion by 2033. This significant growth underscores the critical role of structural heart devices in addressing complex cardiac conditions and improving patient outcomes.
Download Free PDF Sample of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8136
Market Outlook and Growth Projections
The global structural heart devices market is poised for substantial expansion from 2023 to 2033, fueled by the increasing demand for innovative solutions to treat structural heart conditions like atrial septal defects (ASD), ventricular septal defects (VSD), and valve regurgitation. The market is expected to grow from USD 12.17 billion in 2023 to USD 36.06 billion by 2033, registering a CAGR of 11%. This growth is driven by the rising prevalence of cardiovascular diseases, affecting 20–25% of the U.S. population (FactMR), and the shift toward minimally invasive procedures like trans catheter aortic valve replacement (TAVR). The market offers an incremental dollar opportunity of USD 23.89 billion over the forecast period, presenting significant prospects for manufacturers, healthcare providers, and MedTech innovators.
For more information, visit https://www.factmr.com/report/structural-heart-devices-market
Comments
0 comment